Trials in set up

These are brief descriptions of trials currently in set up.  Information will be updated as soon as details are finalised, centres are known and the trials are starting.

ARTEMIDE-Biliary01

Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer (BTC) After Resection 

A global study to assess the efficacy and tolerability of rilvegostomig compared to placebo in combination with investigator’s choice of chemotherapy in participants with BTC after surgical resection with curative intent.

This study is due to open soon at a number of UK sites.  

For more details, see:
https://clinicaltrials.gov/study/NCT06109779

And for information on AstraZeneca’s website, see:
https://www.astrazenecaclinicaltrials.com/study/D7025C00001